Drawing for FRIBEVI

USPTO serial 79262397

FRIBEVI

Reviewed by CopyMark Law Group

Reg. 6044638Status 700Renewal
Filing date
Status date
Registration date
May 5, 2020
Examiner
CIANCI, RYAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FRIBEVI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Zhi Dong

Zhi Dong HAMRE, SCHUMANN, MUELLER & LARSON, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; chemical preparations for pharmaceutical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; Biological preparations for medical purposes for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; injectable pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseases; medicines for use in human for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, and ophthalmic diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 5, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 11, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 18, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 18, 2020FIMPFINAL DISPOSITION PROCESSED—
Aug 5, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jan 29, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 29, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 14, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jan 10, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jan 8, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 13, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2019ALIEASSIGNED TO LIE—
Dec 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2019RFNTREFUSAL PROCESSED BY IB—
Aug 28, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 28, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 9, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 8, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2019DOCKASSIGNED TO EXAMINER—
Jul 16, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance